Mitochondrial dysfunction in peripheral mononuclear blood cells (PBMC) of individuals with mild cognitive impairment

Fabian Dieter1, Karlotta Jacobs2, Alice Quentin1

  • 1Institute of Nutritional Science, Justus-Liebig University, Giessen, Germany.

Geroscience
|August 7, 2025
PubMed

Insights

Mitochondrial dysfunction, indicated by lower ATP levels in peripheral blood cells, is linked to mild cognitive impairment (MCI). This dysfunction correlates with poorer cognitive performance, suggesting accessible blood cells can reveal dementia risk.

Area of Science:

  • Neuroscience
  • Gerontology
  • Biochemistry

Background:

  • Mitochondrial dysfunction is a key factor in aging and neurodegenerative diseases like Alzheimer's.
  • Mild cognitive impairment (MCI) signifies a decline beyond normal aging, often preceding dementia.
  • Investigating peripheral blood cells offers a accessible window into systemic bioenergetic health.

Purpose of the Study:

  • To explore the relationship between mitochondrial function in peripheral blood cells and cognitive performance in individuals with mild cognitive impairment (MCI).
  • To compare mitochondrial function in young adults, healthy older adults, and individuals with amnestic (aMCI) and nonamnestic mild cognitive impairment (naMCI).

Main Methods:

  • A cross-sectional study of 90 participants, including young controls, older controls, and MCI groups.
  • Mitochondrial function assessed via ATP levels and endogenous respiration in cryopreserved peripheral blood mononuclear cells (PBMCs).
  • Cognitive status evaluated using the German Consortium to Establish a Registry for Alzheimer's Disease (CERAD) test battery.

Main Results:

  • Individuals with aMCI showed significantly lower ATP levels in PBMCs compared to young and older controls.
  • The MCI group exhibited the lowest endogenous respiration rates.
  • Higher ATP levels positively correlated with immediate recall and fluency, indicating better cognitive performance.

Conclusions:

  • Mitochondrial dysfunction in PBMCs is associated with MCI and cognitive impairment.
  • Lower ATP levels in blood cells correlate with poorer performance on neuropsychological tests.
  • PBMCs serve as a valuable biomarker for assessing bioenergetic status and dementia risk.